Research

NERI Announces Additional $45M NIH Grant to Support the Pediatric Heart Network

Total funding for all NERI work related to pediatric heart disease swells to $87M

WATERTOWN, Mass., Oct. 25, 2011 /PRNewswire/ -- New England Research Institutes (NERI) today announced that it has received a $45 million grant from the National Institutes of Health (NIH) for the continuance of its work on the Pediatric Heart Network (PHN). PHN is a multi-center clinical research network started in 2001, supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, to study congenital and acquired heart diseases that occur in childhood. This grant provides five more years of funding to nine clinical centers and NERI as the data coordinating center, to conduct clinical research studies in children and young adults with heart defects and other heart diseases.

Congenital heart defects occur in approximately 40,000 infants in the US each year and are a major cause of infant death. The PHN was started by the NHLBI to find treatments for children with heart disease. Nine major studies have been conducted since 2001 at children's hospitals around the US and Canada with research teams that specialize in the care of patients with heart disease. The PHN also provides training in clinical research to new investigators, and is the clinical cornerstone of the NHLBI's comprehensive Bench to Bassinet (B2B) Program in pediatric cardiovascular translational research.

For more information, please visit:
http://www.benchtobassinet.com 

Read the full press release







Link C.L. & McKinlay J.B. Only Half the Problem is being addressed: Underinsurance is as Big a Problem as Uninsurance. Forthcoming, International Journal of Health Services, 2010.
Himmelstein D.U. and Woolhandler S. Massachusetts’ approach to universal coverage: High hopes and faculty economic logic. International Journal of Health Services, Vol. 37(2):251-257, 2007.

Newsroom

Current Newsletters

NERI’s current issue of News & Views features a focus on clinical trials.


Download this newsletter ›› PDF
View all newsletters ››